People with Alzheimer's exhibit a loss of motor control along with cognitive decline, and one of the earliest signs of this decay can be spotted in involuntary eye movements known as saccades. These ...

Alzheimer's disease affects more than 50 million people worldwide, often devastating both the individuals who have it and ...

There's no cure for this disease, but now there is some hope for people and their families who are battling the illness in ...

Alzheimer’s is a disease that knows no stranger. “It’s actually the seventh leading cause of death in the United States,” Pepper said. “It’s estimated that it affects up to about 6 ...

With a new infusion of capital, Chicago-based Synapticure is hoping to improve care access for patients living with ...

The agency also authorized icometrix's AI-driven MRI software to detect and grade amyloid-related imaging abnormalities (ARIA) in Alzheimer's patients treated with amyloid-targeting therapies.

In a groundbreaking development that could revolutionize early detection of Alzheimer’s disease, researchers are exploring ...

New recommendations to help healthcare providers explain amyloid therapies to Alzheimer’s patients and their caregivers involve sharing the benefits and risks of the medications. The Alzheimer ...

[1,2] The treatment was tested in a large 18-month clinical study in patients with mild cognitive impairment (MCI) and mild dementia due to early AD. Even though you cannot stop AD from getting ...

Researchers have developed a cellular fractionation protocol. This method allows for precise analysis of the proteins located in synaptic membranes and in membranes outside the synapses, known as ...